FLACC1: A Potential Drug Target for ALS (G130540)
FLACC1: A Potential Drug Target for ALS
FLACC1 (Amyotrophic Lateral Sclerosis 2 Chromosome Region 12) is a gene that has been identified as a potential drug target or biomarker for the progressive neurodegenerative disease amyotrophic lateral sclerosis (ALS). The FLACC1 gene is located on chromosome 12 and encodes a protein known as FLACC1, which is involved in the regulation of a variety of cellular processes.
Based on recent studies, FLACC1 has been shown to be highly expressed in the brain and is significantly associated with the development and progression of ALS. Additionally, FLACC1 has been shown to play a role in the regulation of the neurotransmitter dopamine, which is known to be involved in the progression of ALS.
One of the key challenges in studying FLACC1 is its expression and function in the disease, as there is limited information available on the subject. However, researchers have identified a number of potential drug targets based on FLACC1's involvement in the disease.
One potential drug target is the FLACC1-containing region of chromosome 12, which has been shown to be a gene expression hotspot in the brain. Researchers have identified a number of potential FLACC1-targeted genes and are exploring the potential for these genes to be used as drug targets.
Another potential drug target is the FLACC1-regulated gene P120, which has been shown to be involved in the regulation of the microtubules of brain cells. Researchers are investigating the potential of P120 as a drug target for ALS.
In addition to these potential drug targets, FLACC1 has also been shown to be involved in the regulation of a variety of cellular processes, including the regulation of cell adhesion, the production of autophagy, and the regulation of inflammation. Researchers are exploring the potential of these processes as potential drug targets for ALS.
Overall, FLACC1 is a promising gene for use as a drug target or biomarker for ALS. Further research is needed to fully understand its role in the disease and to develop effective treatments.
Protein Name: Flagellum Associated Containing Coiled-coil Domains 1
The "FLACC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FLACC1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
FLAD1 | FLCN | FLG | FLG-AS1 | FLG2 | FLI1 | FLII | FLJ12825 | FLJ13224 | FLJ16779 | FLJ20021 | FLJ20712 | FLJ25758 | FLJ30679 | FLJ31945 | FLJ32154 | FLJ32255 | FLJ33534 | FLJ36000 | FLJ37201 | FLJ37786 | FLJ38576 | FLJ39095 | FLJ40194 | FLJ42393 | FLJ42627 | FLJ42969 | FLJ43315 | FLJ44342 | FLJ44635 | FLJ45513 | FLJ46875 | FLNA | FLNB | FLNC | FLOT1 | FLOT2 | FLRT1 | FLRT2 | FLRT3 | FLT1 | FLT3 | FLT3LG | FLT4 | FLVCR1 | FLVCR1-DT | FLVCR2 | FLVCR2-AS1 | FLYWCH1 | FLYWCH2 | FMC1 | FMC1-LUC7L2 | FMN1 | FMN2 | FMNL1 | FMNL2 | FMNL3 | FMO1 | FMO2 | FMO3 | FMO4 | FMO5 | FMO6P | FMO9P | FMOD | FMR1 | FMR1-AS1 | FMR1NB | FN1 | FN3K | FN3KRP | FNBP1 | FNBP1L | FNBP1P1 | FNBP4 | FNDC1 | FNDC10 | FNDC11 | FNDC3A | FNDC3B | FNDC4 | FNDC5 | FNDC7 | FNDC8 | FNDC9 | FNIP1 | FNIP2 | FNTA | FNTB | FOCAD | Focal Adhesion Kinases (FAK) | Folate Receptor | FOLH1 | FOLH1B | Follicle stimulating hormone | FOLR1 | FOLR2 | FOLR3 | Formin homology 2 domain-containing proteins | FOS
